Presentation and surgical intervention for inflammatory myofibroblastic tumor resection of the bladder: case report
PDF (Português (Brasil))

Keywords

Urology
Inflammatory Myofibroblastic Tumor
Benign Bladder Neoplasm
Diagnosis

How to Cite

Bragion, C. B., Venturini, G. S., Hespanha, P. E. M., Santos Júnior, F. E. dos, Gama, R. F., & Castro, M. A. S. (2022). Presentation and surgical intervention for inflammatory myofibroblastic tumor resection of the bladder: case report. Journal of Medical Residency Review, 1(1), e0227. https://doi.org/10.37497/JMRReview.v1i1.6

Abstract

Background: Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm of little known etiology, originating from visceral tissue and soft tissues, which can occur in any area of ​​the body. In the genito-urinary system, it mainly affects the bladder, and may present with hematuria, frequency, dysuria and, more rarely, fever and weight loss. Differential diagnosis by histopathology is essential to determine whether the treatment will be radical or conservative, with partial cystectomy or transurethral resection (TURP) being the first choice for these cases. Case Report: This was a 50-year-old female patient treated at the Urology Service of the Hospital Universitário São Francisco na Providência de Deus – HUSF with complaints of hematuria for one month, suprapubic pain and urge incontinence. A computed tomography scan of the patient's abdomen and pelvis showed a urinary bladder with normal contours and morphology, however, with heterogeneous content due to the presence of an amorphous, endophytic formation, which occupied about one sixth of the organ's volume and with attenuation of hematic tissue.

Based on the findings, it was recommended that the patient undergo a transurethral bladder resection for biopsy. After that, it was then indicated an open resection of the lesion due to its extensive size. The procedure was uneventful, and a complete resection of the lesion, which had a polypoid appearance, was possible.

Conclusion: The case presented is a classic example of urinary bladder IMT.

https://doi.org/10.37497/JMRReview.v1i1.6
PDF (Português (Brasil))

References

CAMELA, F. et al. Pulmonary Inflammatory Myofibroblastic Tumor in Children: A Case Report and Brief Review of Literature. Frontiers in Pediatrics, v. 6, p. 35, 2018.

CESSNA, M. H. et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, v. 15, n. 9, p. 931–938, set. 2002.

CHEN, C. Y. et al. Inflammatory Myofibroblastic Tumor of the Kidney Associated With a Renal Stone. , 2008.

CHENG, L. et al. Inflammatory myofibroblastic tumors of the genitourinary tract--single entity or continuum? The Journal of Urology, v. 180, n. 4, p. 1235–1240, out. 2008.

COLLIN, M. et al. Inflammatory myofibroblastic tumour of the bladder in children: a review. Journal of Pediatric Urology, v. 11, n. 5, p. 239–245, out. 2015.

COSTA, M. L. V. et al. Pseudotumor inflamatório: relato de caso. Rev Med UFC, v. 56, n. 2, p. 67–71, 2016.

DE OLIVEIRA, R. M. et al. Tumor Miofibroblástico Inflamatório. CEP, v. 30150, p. 220, 2017.

FLETCHER, S. G. et al. Regression of inflammatory pseudotumor of the bladder in a child with medical management. Urology, v. 69, n. 5, p. 982.e11–12, maio 2007.

FREEMAN, A. et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, v. 17, n. 7, p. 765–771, jul. 2004.

GARRIDO ABAD, P. et al. [Inflammatory myofibroblastic tumor. Case report]. Archivos Espanoles De Urologia, v. 61, n. 1, p. 62–65, fev. 2008.

HANSEN, C. C. et al. Maxillary sinus inflammatory myofibroblastic tumors: a review and case report. Case Reports in Oncological Medicine, v. 2015, p. 953857, 2015.

KAPUSTA, L. R. et al. Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases. The American Journal of Surgical Pathology, v. 27, n. 5, p. 658–666, maio 2003.

KASANA, V. et al. Inflammatory Myofibroblastic Tumor of Liver Masquerading as Focal Nodular Hyperplasia in a Patient with Non-Cirrhotic Portal Hypertension and Biliary Pancreatitis. Indian Journal of Surgical Oncology, v. 7, n. 1, p. 110–114, mar. 2016.

KUROSAKA, S. et al. Anaplastic Lymphoma Kinase (ALK) and p53 Are Potentially Useful Markers to Distinguish Inflammatory Myofibroblastic Tumor. 2013.

LI, F. et al. Ureteral inflammatory myofibroblastic tumor: A case report and literature review. Medicine, v. 97, n. 46, p. e13177, nov. 2018.

LI, Y.-P. et al. Inflammatory Myofibroblastic Tumor of the Urinary Bladder and Ureter in Children: Experience of a Tertiary Referral Center. Urology, v. 145, p. 229–235, nov. 2020.

MONTGOMERY, E. A. et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. The American Journal of Surgical Pathology, v. 30, n. 12, p. 1502–1512, dez. 2006.

MOSSÉ, Y. P. et al. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, v. 35, n. 28, p. 3215–3221, 1 out. 2017.

ONO, A. et al. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity. Lung Cancer (Amsterdam, Netherlands), v. 99, p. 151–154, set. 2016.

POTHADIYIL, A. J. et al. Inflammatory Myofibroblastic Tumor of the Kidney: A Rare Renal Tumor. Journal of clinical and diagnostic research: JCDR, v. 10, n. 11, p. ED17–ED18, nov. 2016.

POWELL, C. L. et al. Inflammatory Myofibroblastic Tumor: A Case Study. Urology Case Reports, v. 2, n. 5, p. 173–175, set. 2014.

RAZI, A.; RADMEHR, A. Inflammatory pseudotumor of bladder: report of 2 cases and review of literature. Urology Journal, v. 5, n. 1, p. 62–65, 2008.

ROTH, J. A. Reactive pseudosarcomatous response in urinary bladder. Urology, v. 16, n. 6, p. 635–637, dez. 1980.

TSUZUKI, T.; MAGI-GALLUZZI, C.; EPSTEIN, J. I. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. The American Journal of Surgical Pathology, v. 28, n. 12, p. 1609–1614, dez. 2004.

VOELKER, H.-U. et al. Testicular Inflammatory Myofibroblastic Tumor: A Known Entity at a Very Rare Site. Case Reports in Urology, v. 2017, p. 1410843, 2017.

YAGHI, M. D. A case report of inflammatory myofibroblastic tumor of urinary bladder. Urology Annals, v. 8, n. 3, p. 366–368, 2016.

YAGNIK, V. et al. Inflammatory myofibroblastic tumor of the urinary bladder. Urology Annals, v. 2, n. 2, p. 78–79, maio 2010.

ZENG, X. et al. The Clinical and Radiological Characteristics of Inflammatory Myofibroblastic Tumor Occurring at Unusual Sites. BioMed Research International, v. 2018, p. 5679634, 2018.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.